5.4 C
New York
Sunday, February 5, 2023

MCAID Study Cannabis and Driving

Study cannabis and MCAID driving

- Advertisement -

If you are a medical patient or potential patient, Cannabis and drug driving laws It is an important topic that you should be on top of. In Australia, it is illegal to drive with THC in your system in all states and territories, except for Tasmania. In TASI, there is a medical exemption for individuals who test positive but have a prescription. “THC in your system” is defined as a roadside mouth swab that tests positive for THC.

This is a problem because there is no relationship between a positive THC test and a drop. The only way to see the changes in this Discriminatory drug driving laws By gathering researchers for more information about how cannabis affects the ability to drive.

Fortunately, there are people like Dr. Tom Arkell, a psychiatrist and research fellow, who dedicate their lives to studying cannabis and its effect on driving. Tom explains the MCAID study being conducted at Swinburne University in Victoria in this article and accompanying interview. This is what the article covers:

Who runs the experiment and where is it located?

The trial is taking place at the Center for Human Psychopharmacology at Swinburne University in Hawthorne, Victoria (Melbourne). The Department of Health and Human Services funds the MCAID study, which is directed by the Swinburne team. While Swinburne conducts quite a few studies of cannabis and driving, this is the initial study being done.

What is the aim of the study?

The study aims to look at how medical cannabis treatment affects cognitive performance while driving, over a period of time. It obtains a baseline for individuals who have not started cannabis therapy and these patients stay up to three months (12 weeks) in their treatment.

Most studies look at the acute effects of cannabis immediately after vaping or ingesting the oil, for example. In this study, we are interested in finding out how cannabis affects driving and cognition during the first few months of treatment.

The study will help determine if it is in the early stages of treatment, as the individual gets used to the new medicine, when the vulnerability may be greater. Then by testing the patient during the first three months, the study will see how the drug affects the cognitive performance of the individual as the patient finds a stable dose.

Why is this experience important to cannabis patients around the world?

Driving restrictions are one of the biggest barriers patients face. It also creates challenges for health professionals who do not feel comfortable prescribing cannabis due to driving laws.

Driving restrictions are one of the biggest barriers patients face. It also creates challenges for health professionals who do not feel comfortable prescribing cannabis due to driving laws.

One of the main themes of cannabis around the world is the impact of cannabis on leadership and how laws reflect science. While some countries have laws that take science into account and focus on vulnerability, limited research reflects the impact of cannabis on driving in real-world scenarios.

In Australia, most patients end up “giving up” their license if they take cannabis with trace amounts of THC. While it is not a legal requirement, many patients stop driving out of fear.

The MCAID trial is one of the first steps in obtaining real-world evidence of what medical cannabis actually does for driving. Since the study is looking at cannabis and driving over a long period of time and will assess the effects on different forms and doses of delivery, it should be a major step forward in the research.

The data that comes from this study will be able to be used by clinicians, patients and policy makers to establish better guidance about cannabis and drug driving.

How does the study work?

The team is looking for patients who are about to use medicinal cannabis for the first time. The goal is for new patients (or those who have not used cannabis in the last 30 days) to have their first session with the research team between the time they see their doctor and when they take their first dose.

In the first session, the team will take basic measures to demonstrate the patient’s driving skills and awareness before starting to use cannabis. Thereafter, patients return to Swinburne every month at one, two, and three months.

On the first, second, and third visits, you will take your usual dose of medicinal cannabis as prescribed by your doctor. You will then complete a series of tasks (including a driving simulation task and cognitive assessments) and questionnaires. You will also be asked to provide oral fluid samples to the team to determine how much THC is in your saliva.

This research team will give a comprehensive picture of the patient’s cognitive leadership and performance in the various stages of treatment.

What are the requirements for individuals to participate in the trial?

There are no restrictions on the type of product. The product or prescriber is at the discretion of your doctor. Dr. Tom Arkell said, “This is part of what we are reviewing. It is a naturalistic study where we simply monitor patients while they are using the product that a doctor usually prescribes, and exactly how they prescribe it.”

What are the costs to the patient and is there a fee?

The only cost to the patient is their time as a research participant. You will not be allowed to drive to school. However, there are payments for travel in the gross pay.

Sessions range from two to four hours. The first session is a little shorter, sessions in the first, second and third months are between three and four hours.

To complete the study you get $800. It was divided into:

  • $150 per session = $600
  • $200 to complete all sessions = $200
  • Total = $800
Are you looking for medical marijuana growing guides and books about cannabis? Then you should not miss our online bookstore with hundreds of books about marijuana.
Grow guide for marijuana beginners.
- Advertisement -THC University

Related Articles


Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Stay Connected

- Advertisement -

Latest Articles